IDEX Biometrics ASA
IDXAF
$0.89
$0.69345.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -41.93% | -70.24% | -84.23% | -87.90% | -82.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -41.94% | -70.23% | -84.22% | -87.89% | -82.59% |
| Cost of Revenue | -60.64% | -63.84% | -17.35% | -41.61% | -52.65% |
| Gross Profit | 71.73% | 57.45% | -261.76% | -757.24% | -2,563.33% |
| SG&A Expenses | -54.29% | -70.24% | -66.49% | -59.90% | -50.12% |
| Depreciation & Amortization | -83.37% | -81.16% | 12.28% | -44.89% | 35.25% |
| Other Operating Expenses | -29.81% | -28.11% | -8.93% | -17.01% | -21.08% |
| Total Operating Expenses | -49.42% | -54.84% | -37.37% | -37.87% | -31.94% |
| Operating Income | 49.65% | 54.25% | 34.50% | 33.30% | 25.42% |
| Income Before Tax | 25.06% | 32.11% | 30.03% | 64.27% | 47.09% |
| Income Tax Expenses | 63.44% | 66.17% | -1,056.47% | -1,455.00% | -488.00% |
| Earnings from Continuing Operations | 24.71% | 31.83% | 31.14% | 64.96% | 47.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.71% | 31.83% | 31.14% | 64.96% | 47.52% |
| EBIT | 49.65% | 54.25% | 34.50% | 33.30% | 25.42% |
| EBITDA | 43.58% | 50.23% | 39.57% | 37.63% | 34.86% |
| EPS Basic | 91.67% | 96.52% | 85.56% | 96.01% | 72.21% |
| Normalized Basic EPS | 94.93% | 98.11% | 78.82% | 91.68% | 68.21% |
| EPS Diluted | 91.55% | 96.49% | 85.71% | 96.14% | 73.68% |
| Normalized Diluted EPS | 94.93% | 98.11% | 78.80% | 91.65% | 68.09% |
| Average Basic Shares Outstanding | -79.50% | 7,002.46% | 8,160.66% | 8,157.37% | 8,160.72% |
| Average Diluted Shares Outstanding | -79.50% | 6,995.63% | 8,144.19% | 8,133.68% | 8,132.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |